Plasminogen, human Pregnancy and Breastfeeding Warnings
Brand names: Ryplazim
Medically reviewed by Drugs.com. Last updated on Feb 21, 2023.
Plasminogen, human Pregnancy Warnings
Safety is unknown, and the manufacturer makes no recommendation regarding use during pregnancy.
US FDA pregnancy category: Not assigned
Risk summary: There are no data available on the use of this drug in pregnant women to inform a drug-related risk.
Animal studies have not been reported. There are no controlled data in human pregnancy.
Plasminogen, human Breastfeeding Warnings
Safety has not been established. The benefits of breastfeeding should outweigh the risk of potential adverse reactions.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments: Endogenous plasminogen is excreted in human milk; however, the effects of this drug on the nursing infant or milk production are unknown.
See also
References for pregnancy information
- (2022) "Product Information. Ryplazim (plasminogen, human)." Prometic Biotherapeutics Inc
References for breastfeeding information
- (2022) "Product Information. Ryplazim (plasminogen, human)." Prometic Biotherapeutics Inc
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
